<DOC>
	<DOCNO>NCT00051532</DOCNO>
	<brief_summary>The purpose study determine whether seocalcitol effective treatment advance primary liver cancer ( hepatocellular carcinoma [ HCC ] ) .</brief_summary>
	<brief_title>Seocalcitol Versus Placebo Advanced Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Seocalcitol</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>Hospital outpatient Either sex Aged 1875 year With hepatocellular carcinoma , verified histology/cytology , amenable curative treatment transplantation . Patients must measurable disease , classifiable Barcelona Clinic Liver Cancer ( BCLC ) stage 0 , describe Llovet JM et al . Hepatology 1999 ; 29:6267 . Patients treat chemotherapy anticancer therapy within 4 week visit 1 Patients another primary tumor , except basocellular carcinoma skin situ carcinoma cervix , within last 2 year A history renal stone ( ) A life expectancy &lt; 3 month World Health Organization ( WHO ) performance status 3 4 Okuda stage III . Patients hypercalcemia , clinically important laboratory abnormality Patients previous/current calcium metabolic disease , take calciumlowering therapy , medication know affect systemic calcium metabolism also exclude . All patient must give sign informed consent join study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2005</verification_date>
	<keyword>hepatocellular</keyword>
	<keyword>carcinoma</keyword>
	<keyword>liver</keyword>
	<keyword>cancer</keyword>
</DOC>